Guardant Health Inc (GH)

Guardant Health Inc (GH) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $21.9B; returns 1 day +3.8%, 1 week +6.6%, 1 year +143.8%.

Guardant Health Inc. (GH) is a precision oncology company headquartered in Palo Alto, California, specializing in blood-based genomic testing through its proprietary liquid biopsy technology. The company's business model is primarily driven by three revenue segments: Oncology, Biopharma & Data, and Screening.

Groups GH belongs to

• Healthcare
• Oncology
• Precision Medicine
• Biotechnology
• Health Diagnostics and Imaging
• Life Sciences
• Commercial Stage Biotech
• Early Cancer Detection
• Healthcare Technology
• Medical Devices
• Life Sciences Tools & Services

GH financial model: income statement, cash flow and balance sheet